Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$17.18
+0.5%
$16.45
$13.12
$17.58
$872.66M1.56307,071 shs138,177 shs
Elementis plc stock logo
ELMTY
Elementis
$7.48
$7.53
$4.85
$7.58
$1.10B0.9841 shsN/A
Northgate plc stock logo
NGTEF
Northgate
$5.36
$5.36
$5.29
$5.87
$714.11M0.4513,785 shsN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
$1.68
$1.36
$6.24
$2.13M2.67621,231 shs855,100 shs
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$89.50
+0.2%
$94.62
$32.42
$111.44
$4.61B0.671,177 shs457 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
0.00%+0.53%+6.31%+13.70%+25.86%
Elementis plc stock logo
ELMTY
Elementis
0.00%0.00%-1.32%-0.40%+25.71%
Northgate plc stock logo
NGTEF
Northgate
0.00%0.00%0.00%0.00%0.00%
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
0.00%0.00%0.00%0.00%0.00%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.00%+3.15%-2.51%+31.70%+167.96%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
0.81 of 5 stars
1.23.01.70.03.30.01.3
Elementis plc stock logo
ELMTY
Elementis
N/AN/AN/AN/AN/AN/AN/AN/A
Northgate plc stock logo
NGTEF
Northgate
N/AN/AN/AN/AN/AN/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
N/AN/AN/AN/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
2.33
Hold$16.00-6.87% Downside
Elementis plc stock logo
ELMTY
Elementis
N/AN/AN/AN/A
Northgate plc stock logo
NGTEF
Northgate
N/AN/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
N/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
3.00
BuyN/AN/A

Current Analyst Ratings

Latest NGTEF, ZLDPF, SNDE, ELMTY, and CGBD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/7/2024
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
2/28/2024
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$101.09M8.63$2.06 per share8.33$16.99 per share1.01
Elementis plc stock logo
ELMTY
Elementis
$713.40M1.54$0.82 per share9.15$5.77 per share1.30
Northgate plc stock logo
NGTEF
Northgate
$863.72M0.83N/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
$203.58M0.00N/A0.24$51.40 per share0.00
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$49.75M92.67N/AN/A$2.24 per share39.96

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$92.28M$1.6910.179.04N/A38.19%12.80%5.54%5/7/2024 (Confirmed)
Elementis plc stock logo
ELMTY
Elementis
$26.50MN/A0.0011.87N/AN/AN/AN/AN/A
Northgate plc stock logo
NGTEF
Northgate
N/AN/A0.0010.72N/AN/AN/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
-$39.59M-$0.58N/AN/AN/A-291.44%-21.96%-8.64%N/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$102.13M-$1.82N/AN/AN/A-203.99%-49.78%-37.76%N/A

Latest NGTEF, ZLDPF, SNDE, ELMTY, and CGBD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$0.52N/A-$0.52N/AN/AN/A  
2/27/2024Q4 2023
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$0.58-$0.66-$0.08-$0.66$1.97 million$3.35 million
2/26/202412/31/2023
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$0.51$0.52+$0.01$0.55$42.86 million$62.69 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
$1.609.31%+2.36%94.67%N/A
Elementis plc stock logo
ELMTY
Elementis
$0.070.94%N/AN/AN/A
Northgate plc stock logo
NGTEF
Northgate
N/AN/AN/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
N/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/A

Latest NGTEF, ZLDPF, SNDE, ELMTY, and CGBD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2024
Elementis plc stock logo
ELMTY
Elementis
$0.07175/2/20245/3/20246/17/2024
2/20/2024
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
Quarterly$0.4811.84%3/27/20243/29/20244/17/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
1.14
1.22
1.22
Elementis plc stock logo
ELMTY
Elementis
0.31
2.20
1.17
Northgate plc stock logo
NGTEF
Northgate
N/AN/AN/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
N/A
0.13
0.13
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/A
7.63
7.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
24.51%
Elementis plc stock logo
ELMTY
Elementis
N/A
Northgate plc stock logo
NGTEF
Northgate
N/A
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
4.31%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Carlyle Secured Lending, Inc. stock logo
CGBD
Carlyle Secured Lending
N/A50.80 million50.56 millionOptionable
Elementis plc stock logo
ELMTY
Elementis
1,281146.96 millionN/ANot Optionable
Northgate plc stock logo
NGTEF
Northgate
N/A133.23 millionN/ANot Optionable
Sundance Energy Inc. stock logo
SNDE
Sundance Energy
796.88 millionN/ANot Optionable
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
25351.51 millionN/ANot Optionable

NGTEF, ZLDPF, SNDE, ELMTY, and CGBD Headlines

SourceHeadline
Explainer: Does Zambias bondholder deal mean it has resolved its default?Explainer: Does Zambia's bondholder deal mean it has resolved its default?
msn.com - May 2 at 2:27 PM
India, New Zealand Elevate Partnership in Pharmaceuticals, Digital Trade, and Payment InfrastructureIndia, New Zealand Elevate Partnership in Pharmaceuticals, Digital Trade, and Payment Infrastructure
devdiscourse.com - May 2 at 9:26 AM
Govts Pharmac funding boost doesnt go far enough, advocate saysGovt's Pharmac funding boost 'doesn't go far enough', advocate says
msn.com - May 1 at 9:49 AM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Growth in Short InterestZealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Growth in Short Interest
americanbankingnews.com - April 30 at 1:40 AM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Short Interest UpdateZealand Pharma A/S (OTCMKTS:ZLDPF) Short Interest Update
marketbeat.com - April 29 at 11:31 AM
Pharmacs budget boosted to $6.3b over next four yearsPharmac's budget boosted to $6.3b over next four years
msn.com - April 29 at 10:10 AM
Pharmac ponders glucose monitor fundingPharmac ponders glucose monitor funding
waateanews.com - April 26 at 8:19 AM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 1.3%Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 1.3%
marketbeat.com - April 25 at 12:21 AM
Auckland to Northland expressway will boost GDP by $1.2b a year, report showsAuckland to Northland expressway will boost GDP by $1.2b a year, report shows
msn.com - April 17 at 8:07 AM
A Double-Dip Recession in the Land of the Long White CloudA Double-Dip Recession in the Land of the Long White Cloud
bloomberg.com - April 17 at 8:07 AM
New Zealand strengthens military alliance with USNew Zealand strengthens military alliance with US
wsws.org - April 13 at 12:41 PM
New Zealand welcomes input on draft biometrics codeNew Zealand welcomes input on draft biometrics code
biometricupdate.com - April 12 at 9:32 PM
Aucklands newest social supermarket officially opensAuckland's newest social supermarket officially opens
msn.com - April 11 at 7:41 AM
Unveiling New Zealands Most Deadly Urban Pest: A Comprehensive ExaminationUnveiling New Zealand's Most Deadly Urban Pest: A Comprehensive Examination
markets.businessinsider.com - April 3 at 8:41 PM
Total number of shares and voting rights in Zealand Pharma at March 31, 2024Total number of shares and voting rights in Zealand Pharma at March 31, 2024
finance.yahoo.com - March 31 at 2:26 PM
Increase in opioid use in New Zealand should spark concern - researchersIncrease in opioid use in New Zealand 'should spark concern' - researchers
msn.com - March 18 at 2:04 AM
New migrants lead New Zealand for childhood vaccinationNew migrants lead New Zealand for childhood vaccination
medicalxpress.com - March 13 at 10:17 PM
New Zealand Food Price Inflation Weakest Since 2021New Zealand Food Price Inflation Weakest Since 2021
markets.businessinsider.com - March 13 at 2:14 AM
New Zealand banks to report material cyber incidents within 72 hoursNew Zealand banks to report material cyber incidents within 72 hours
complianceweek.com - March 11 at 2:46 PM
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care ConferenceZealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
finance.yahoo.com - March 1 at 2:03 PM
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care ConferenceZealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
finance.yahoo.com - March 1 at 2:03 PM
Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call TranscriptZealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 1 at 12:53 AM
Zealand Pharma convenes its Annual General Meeting 2024Zealand Pharma convenes its Annual General Meeting 2024
globenewswire.com - February 27 at 1:05 AM
Zealand shares surge on liver drug data from Boehringer pactZealand shares surge on liver drug data from Boehringer pact
msn.com - February 26 at 4:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Carlyle Secured Lending logo

Carlyle Secured Lending

NASDAQ:CGBD
Carlyle Secured Lending, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.
Elementis logo

Elementis

OTCMKTS:ELMTY
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors. The Personal Care segment provides rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. The company offers personal care products for antiperspirants, color cosmetics, and skin care applications; and performance specialties products for architectural coatings, adhesives, sealants and construction additives, and talc applications. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
Northgate logo

Northgate

OTCMKTS:NGTEF
Northgate plc provides light commercial vehicle hire services in the United Kingdom, Spain, and the Republic of Ireland. It also sells used vehicles; supplies other related goods and services; and offers fleet management services. The company operates a fleet of 53,000 vehicles from 77 locations in the United Kingdom; and a fleet of 40,000 vehicles from 24 locations in Spain. It serves construction and distribution, manufacturing and engineering, and business service industries, as well as local authorities, public utilities, and retailers and wholesalers. The company was founded in 1981 and is headquartered in Darlington, the United Kingdom.
Sundance Energy logo

Sundance Energy

NASDAQ:SNDE
Sundance Energy Inc. operates as an onshore independent oil and natural gas company in North America. The company explores for, develops, and produces oil and natural gas. It focuses on operations on its 41,000 net acres in the Eagle Ford, Live Oak, Atascosa, La Salle, and McMullen counties, South Texas. Sundance Energy, Inc. is headquartered in Denver, Colorado.
Zealand Pharma A/S logo

Zealand Pharma A/S

OTCMKTS:ZLDPF
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.